Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 1,327 shares of Varian Medical Systems stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $110.90, for a total transaction of $147,164.30. Following the completion of the transaction, the senior vice president now owns 30,551 shares of the company’s stock, valued at approximately $3,388,105.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
VAR traded up $1.32 during trading on Friday, hitting $105.29. The stock had a trading volume of 885,531 shares, compared to its average volume of 678,674. The stock has a market capitalization of $10.25 billion, a P/E ratio of 29.25, a P/E/G ratio of 3.15 and a beta of 0.78. Varian Medical Systems, Inc. has a twelve month low of $99.00 and a twelve month high of $130.29.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 25th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.05. The company had revenue of $709.10 million for the quarter, compared to analysts’ expectations of $663.19 million. Varian Medical Systems had a net margin of 4.07% and a return on equity of 27.51%. Varian Medical Systems’s revenue was up 12.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 EPS. On average, sell-side analysts anticipate that Varian Medical Systems, Inc. will post 4.45 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently modified their holdings of the business. Intact Investment Management Inc. purchased a new stake in shares of Varian Medical Systems during the 2nd quarter worth $205,000. Motley Fool Wealth Management LLC boosted its position in shares of Varian Medical Systems by 3.3% in the 2nd quarter. Motley Fool Wealth Management LLC now owns 48,918 shares of the medical equipment provider’s stock worth $5,563,000 after buying an additional 1,548 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Varian Medical Systems by 81.0% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 64,102 shares of the medical equipment provider’s stock worth $7,290,000 after buying an additional 28,680 shares in the last quarter. Sei Investments Co. boosted its position in shares of Varian Medical Systems by 66.8% in the 2nd quarter. Sei Investments Co. now owns 35,014 shares of the medical equipment provider’s stock worth $3,982,000 after buying an additional 14,024 shares in the last quarter. Finally, Toronto Dominion Bank boosted its position in shares of Varian Medical Systems by 19.4% in the 2nd quarter. Toronto Dominion Bank now owns 58,802 shares of the medical equipment provider’s stock worth $6,686,000 after buying an additional 9,563 shares in the last quarter. Institutional investors own 92.44% of the company’s stock.
VAR has been the topic of a number of recent research reports. JPMorgan Chase & Co. cut shares of Varian Medical Systems from a “neutral” rating to an “underweight” rating and set a $105.00 target price on the stock. in a report on Thursday, June 28th. Zacks Investment Research cut shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Tuesday, September 25th. Finally, Royal Bank of Canada set a $115.00 target price on shares of Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, October 4th. Four analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $117.43.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.
Featured Article: Fundamental Analysis – How It Helps Investors
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.